Submitted by: Submitted by nagasarat
Views: 516
Words: 5276
Pages: 22
Category: Business and Industry
Date Submitted: 06/27/2010 01:23 AM
CONTENTS
ABSTACT………………………………………….. 01
CHAPTER - I
INTRODUCTION
OBJECTIVES OF THE STUDY
SCOPE AND SIGNIFICANCE OF THE STUDY
METHODOLOGY
LIMITATIONS OF THE STUDY
ORGANIZATION OF THE STUDY
CHAPTER – II
INDUSTRY PROFILE
CHAPTER – III
COMPANY PROFILE
CHAPTER – IV
FINANCIAL ANALYSIS OVERVIEW
CHAPTER – V
FINANCIAL ANALYSIS AND INTERPRETATION
CHAPTER – VI
FINDINGS
CONCLUSION
BIBILOGRAPHY
ABSTRACT
The Indian biotech industry in 2004-05 registered revenues of Rs. 4,745 crore recording a 36% growth compared to the previous year. This sector offers good growth potential. Drug molecule development and allied services are growth areas in bio pharma industry and successful product innovations results in company commanding good premium in the market.
The project was conducted to know about the bio pharma industry in India and to know about the Celestial Labs Ltd. The financial performance of the company is analyzed and how the company is performing in the past few years.
One of the main findings was that the company having a considerable increase in total profit which shows the operating efficiency of the company. The main suggestions was the company should keep the working capital as ideal, if it is high, indicates the wastage of money otherwise inadequate working capital.
INTRODUCTION
Finance is regarded as the lifeblood of a business enterprise. The test of success of business enterprise is its ability to earn profits and continue its operation and growth. Profit earning is considered essential for the survival of business. A business needs profits not only for existence but also for its expansion and diversification. Profitability is barometer for measuring efficiency and economic prosperity of a business enterprise.
Financial statements:
Financial statements are the basis for decision making by the management as well as other outsiders who are interested in the affairs of the firm such as investors, creditors, customers, suppliers,...